Biotechnology
Scienture Launches Commercial Sales of Arbli™, the First FDA-Approved Ready-to-Use Losartan Suspension
$256 million U.S. market opportunity drives expansion as company kicks off multi-channel promotional campaign Scienture Holdings (SCNX) announced the official...
Genprex Shares Gain as Positive Preclinical Lung Cancer Data to Be Presented at Global Oncology Conference
REQORSA® gene therapy shows promise against hard-to-treat ALK-positive non-small cell lung cancer Clinical-stage gene therapy developer Genprex (GNPX) announced that...
Wall Street’s Biggest Analyst Calls Today: Upgrades Favor Tech, Downgrades Hit Industrials and Healthcare
Semiconductor optimism drives bullish calls on AMD and Monolithic Power while managed care stocks come under pressure Wall Street analysts...
J&J Eyes Biotech Buyout to Strengthen Immunology Pipeline
Prospective acquisition of Protagonist Therapeutics centers on oral drug for immune diseases Johnson & Johnson (JNJ) is reportedly in active...
Envoy Medical Advances to Final Stage of FDA Trial for Fully Implanted Cochlear Implant
Positive early results accelerate timeline and reduce capital needs by up to $15 million Envoy Medical (COCH), a Minnesota-based hearing...
Drugmakers Gain as Markets Digest Trump’s Proposed 100% Pharma Tariffs
Exemptions for U.S. plant construction and existing expansion plans temper immediate fallout, but uncertainty remains for smaller firms Shares of...
Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast
Telehealth company maintains 2025 outlook, expands beyond GLP-1 offerings amid regulatory and partnership setbacks Hims & Hers Health (HIMS) stock...
ProMIS Neurosciences Soars 160% After FDA Fast Track Designation for Alzheimer’s Drug
PMN310 aims to deliver a safer, next-generation treatment by targeting toxic amyloid-beta in early-stage Alzheimer’s patients Shares of ProMIS Neurosciences...
Regencell Bioscience’s Stock Whipsaws Again Amid 17,000% Surge in 2025
Following a 38-to-1 stock split and explosive rally, the biotech firm's volatile trading persists despite a multi-year loss streak Regencell...
KindlyMD and Nakamoto Merge to Launch Largest Bitcoin Treasury Initiative in Public Markets
$710 Million Raised as David Bailey Leads Ambitious Plan to Transform Bitcoin Adoption Through Public Equity In a landmark move...
